Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
97.88
+0.94 (0.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Zimmer Biomet Holdings stock have an average target of 124.15, with a low estimate of 107 and a high estimate of 150. The average target predicts an increase of 26.84% from the current stock price of 97.88.
Analyst Consensus: Buy
* Price targets were last updated on Feb 10, 2025.
Analyst Ratings
The average analyst rating for Zimmer Biomet Holdings stock from 22 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Hold | 13 | 12 | 12 | 12 | 12 | 11 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 22 | 21 | 22 | 23 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Reiterates $118 → $113 | Hold | Reiterates | $118 → $113 | +15.45% | Feb 10, 2025 |
| Barclays | Barclays | Sell Maintains $118 → $112 | Sell | Maintains | $118 → $112 | +14.43% | Feb 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $130 → $125 | Buy | Maintains | $130 → $125 | +27.71% | Feb 7, 2025 |
| Raymond James | Raymond James | Buy Maintains $126 → $119 | Buy | Maintains | $126 → $119 | +21.58% | Feb 7, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $140 | Buy | Reiterates | $140 | +43.03% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
7.97B
from 7.68B
Increased by 3.82%
Revenue Next Year
8.35B
from 7.97B
Increased by 4.74%
EPS This Year
8.29
from 4.43
Increased by 87.10%
EPS Next Year
8.94
from 8.29
Increased by 7.86%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.5B | 9.0B | 9.3B | ||
| Avg | 8.0B | 8.4B | 8.7B | ||
| Low | 7.7B | 8.0B | 8.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.1% | 12.7% | 11.0% | ||
| Avg | 3.8% | 4.7% | 3.9% | ||
| Low | -0.2% | -0.2% | -1.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.74 | 9.68 | 10.90 | ||
| Avg | 8.29 | 8.94 | 9.71 | ||
| Low | 7.78 | 8.31 | 9.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 97.2% | 16.8% | 22.0% | ||
| Avg | 87.1% | 7.9% | 8.6% | ||
| Low | 75.6% | 0.3% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.